RUTHERFORD, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and ...

XORTX’s presentation will be recorded and available after the conference on the Company’s website. About XORTX Therapeutics Inc.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Life, death, taxes and the Mediterranean Diet meal plan dominating nutrition-related headlines each January are four of the ...

These two well-established weight loss companies can help make weight loss easier, but there are major differences in their programs.